XML 141 R123.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-Based Compensation - Weighted average assumptions used in valuing options (Details) - USD ($)
1 Months Ended 12 Months Ended 90 Months Ended
Jun. 07, 2020
Jun. 30, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Jun. 30, 2009
Oct. 29, 2020
Employee Stock Purchase Plan              
Additional disclosures              
Compensation expense     $ 126,000 $ 81,000 $ 75,000    
Employee Stock Purchase Plan              
Number of shares of common stock registered in connection with the establishment of an Employee Stock Purchase Plan     363,825       1,400,000
Requisite age of employees to be eligible to participate in the plan     21 years        
Requisite service period to be eligible to participate in the plan     6 months        
Employee stock purchases (in shares)     33,013 32,476 21,100    
Discount rate for eligible employees to purchase company stock (as a percent)     5.00%     15.00%  
Minimum | Employee Stock Purchase Plan              
Employee Stock Purchase Plan              
Shares available for issuance under the plan     1,400,000        
Maximum | Employee Stock Purchase Plan              
Employee Stock Purchase Plan              
Estimated subscription date fair value (as a percent)     95.00%        
Stock Options              
Additional disclosures              
Total unrecognized compensation cost related to non vested stock option grants     $ 0 $ 0 $ 720,000    
Total fair value of shares vested during the period     0 1,400,000 799,000    
Compensation expense     $ 0 $ 720,000 641,000    
Restricted Stock Activity              
Assumed restricted stock shares from CSFL merger (in shares)       136,831      
Weighted-Average Grant-Date Fair Value              
Assumed restricted stock shares from CSFL merger (in dollars per share)       $ 37.85      
Stock Options | CSFL              
Additional disclosures              
Vesting of stock options   $ 481,000   $ 704,000      
Restricted Stock              
Share-Based Compensation              
Options vested (in shares)     25,937        
Additional disclosures              
Weighted-average period over which unrecognized compensation cost is expected to be recognized     2 years 7 months 24 days        
Compensation expense     $ 370,000 $ 1,500,000 $ 1,700,000    
Options vested (in shares)     25,937        
Restricted Stock Activity              
Outstanding at the beginning of the period (in shares)     11,004        
Granted (in shares)     0 9,145 8,934    
Vested (in shares)     (7,938)        
Outstanding at the end of the period (in shares)     3,066 11,004      
Weighted-Average Grant-Date Fair Value              
Outstanding at the beginning of the period (in dollars per share)     $ 59.42        
Granted (in dollars per share)     0 $ 55.96 $ 73.34    
Vested (in dollars per share)     56.43        
Outstanding at the end of the period (in dollars per share)     $ 67.31 $ 59.42      
Additional disclosures              
Total unrecognized compensation cost related to nonvested restricted stock and RSUs granted     $ 166,000        
Total fair value of shares vested during the period     448,000 $ 4,600,000 $ 3,000,000.0    
Employee Stock Purchase Plan              
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value     $ 448,000 4,600,000 3,000,000.0    
Restricted Stock | Maximum              
Additional disclosures              
Vesting period     12 months        
Restricted Stock | Employees | Minimum              
Additional disclosures              
Vesting period     4 years        
Restricted Stock | CSFL              
Restricted Stock Activity              
Vested (in shares) (29,303)            
Restricted Stock Units              
Additional disclosures              
Weighted-average period over which unrecognized compensation cost is expected to be recognized     1 year 8 months 12 days        
Compensation expense     $ 25,200,000 $ 21,000,000.0 $ 6,400,000    
Restricted Stock Activity              
Outstanding at the beginning of the period (in shares)     750,821        
Granted (in shares)     301,230 382,205 159,521    
Vested (in shares)     (93,081)        
Forfeited (in shares)     (10,757)        
Outstanding at the end of the period (in shares)     948,213 750,821      
Weighted-Average Grant-Date Fair Value              
Outstanding at the beginning of the period (in dollars per share)     $ 60.88        
Granted (in dollars per share)     81.14        
Vested (in dollars per share)     64.66        
Forfeited (in dollars per share)     64.20        
Outstanding at the end of the period (in dollars per share)     $ 67.01 $ 60.88      
Additional disclosures              
Total unrecognized compensation cost related to nonvested restricted stock and RSUs granted     $ 26,200,000        
Total fair value of shares vested during the period     $ 6,000,000.0 $ 23,600,000 $ 5,800,000    
Target RSU award level (as a percent)     1.00%        
Employee Stock Purchase Plan              
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value     $ 6,000,000.0 $ 23,600,000 $ 5,800,000    
Restricted Stock Units | CSFL              
Additional disclosures              
Vesting of stock options   $ 7,500,000          
Restricted Stock Activity              
Vested (in shares) (242,018)            
Performance based restricted stock units              
Additional disclosures              
Performance period     3 years        
Other Performance based restricted stock units | Minimum              
Additional disclosures              
Performance period     1 year        
Other Performance based restricted stock units | Maximum              
Additional disclosures              
Performance period     2 years        
Timed based restricted stock units | Minimum              
Additional disclosures              
Performance period     2 years        
Timed based restricted stock units | Maximum              
Additional disclosures              
Performance period     4 years